| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 437,495 | 252,539 |
| Depreciation and amortization | 242,498 | 160,384 |
| Impairment on real estate properties | 16,594 | 15,450 |
| Straight-line rent and other write-offs | 27,537 | - |
| Recovery for credit losses | -3,587 | 321 |
| Amortization of deferred financing costs and loss on debt extinguishment | 3,458 | 2,396 |
| Stock-based compensation expense | 34,323 | 25,046 |
| Gain on assets sold - net | 61,230 | 32,961 |
| Straight-line rent and other write-offs | - | 27,537 |
| Straight-line rent and effective interest receivables | 36,944 | 23,526 |
| Interest paid-in-kind | -9,346 | -4,996 |
| Loss (income) from unconsolidated entities | 5,688 | 3,066 |
| Other non-cash items | 10,534 | 4,358 |
| Contractual receivables | -53 | -1,059 |
| Lease inducements | 9,269 | 9,497 |
| Other operating assets and liabilities | -11,195 | -8,757 |
| Net cash provided by operating activities | 647,931 | 421,217 |
| Acquisition of real estate | 627,844 | 560,422 |
| Net proceeds from sale of real estate investments | 264,061 | 182,995 |
| Investments in construction in progress | 31,479 | 29,731 |
| Investment in loan receivables and other | 140,882 | 109,767 |
| Collection of loan principal | 120,357 | 100,297 |
| Investments in unconsolidated entities | 77,244 | 1,250 |
| Distributions from unconsolidated entities in excess of earnings | 9,969 | 1,466 |
| Capital improvements to real estate investments | 54,176 | 32,941 |
| Proceeds from derivative instruments | -4,675 | -4,675 |
| Receipts from insurance proceeds | 4,478 | 392 |
| Net cash used in investing activities | -528,085 | -444,286 |
| Proceeds from long-term borrowings | 670,708 | 670,708 |
| Payments of long-term borrowings | 528,496 | 527,240 |
| Payments of financing related costs | 25,600 | 6,540 |
| Net proceeds from issuance of common stock | 606,810 | 517,851 |
| Dividends paid | 581,996 | 383,785 |
| Redemption of omega op units | 5,768 | 3,681 |
| Distributions to omega op unit holders | 33,451 | 26,056 |
| Net cash provided by (used in) financing activities | 102,207 | 241,257 |
| Effect of foreign currency translation on cash, cash equivalents and restricted cash | 4,216 | 5,661 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 226,269 | 223,849 |
| Cash and cash equivalents at beginning of period | 548,735 | - |
| Cash and cash equivalents at end of period | 775,004 | - |
OMEGA HEALTHCARE INVESTORS INC (OHI)
OMEGA HEALTHCARE INVESTORS INC (OHI)